In partnership with Geisinger’s large patient population, MyCode^TM will help unlock the mysteries of some of the most devastating and debilitating diseases.

MyCode capitalizes on Geisinger’s advanced ability to link genomic information with its electronic health record system in a way that protects patient identity.

Researchers use the blood samples to study the genetic contribution to a wide range of human diseases. Knowledge gained from these studies will allow researchers to pursue innovative approaches to disease prevention, diagnosis and treatment.